Biosense Webster Receives FDA Approval for Multiple Atrial Fibrillation Ablation Products to be Used in a Workflow Without Fluoroscopy
Approval based on data from REAL AF Registry, demonstrating value of real-world evidence
Stay updated with breaking news from Circulation Research. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Approval based on data from REAL AF Registry, demonstrating value of real-world evidence
/PRNewswire/ -- Biosense Webster, Inc., a global leader in cardiac arrhythmia treatment and part of Johnson & Johnson MedTech,i today announced that several...
Biosense Webster, Inc., a global leader in cardiac arrhythmia treatment and part of Johnson & Johnson MedTech,i today announced the U.S. launch of the OPTRELL™ Mapping Catheter with TRUEref™ Technology powered by the CARTO® 3 System. The OPTRELL™ Mapping Catheter is a high-density diagnostic catheter, with small ...
Postdoctoral Scientists, Associate Research Scientists, or Research Scientists in Full time, Postdoctoral, Biomedicine with Yale School of Medicine (YSM). Apply Today.
Atrial fibrillation (AFib) is the most common type of heart arrhythmia. This serious condition occurs when the heart beats so fast that the upper chambers of the heart quiver.